Research ArticleArticle
Metabolism and Disposition of Verinurad, a Uric Acid Reabsorption Inhibitor, in Humans
Caroline A. Lee, Chun Yang, Vishal Shah, Zancong Shen, David M Wilson, Traci M. Ostertag, Jesse Hall, Jean-Luc Girardet and Michael Gillen
Drug Metabolism and Disposition February 28, 2018, dmd.117.078220; DOI: https://doi.org/10.1124/dmd.117.078220
Caroline A. Lee
1 Ardea Biosciences, Inc.;
Chun Yang
1 Ardea Biosciences, Inc.;
Vishal Shah
1 Ardea Biosciences, Inc.;
Zancong Shen
1 Ardea Biosciences, Inc.;
David M Wilson
1 Ardea Biosciences, Inc.;
Traci M. Ostertag
1 Ardea Biosciences, Inc.;
Jesse Hall
1 Ardea Biosciences, Inc.;
Jean-Luc Girardet
1 Ardea Biosciences, Inc.;
Michael Gillen
2 AstraZeneca

Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Metabolism and Disposition of Verinurad, a Uric Acid Reabsorption Inhibitor, in Humans
Caroline A. Lee, Chun Yang, Vishal Shah, Zancong Shen, David M Wilson, Traci M. Ostertag, Jesse Hall, Jean-Luc Girardet and Michael Gillen
Drug Metabolism and Disposition February 28, 2018, dmd.117.078220; DOI: https://doi.org/10.1124/dmd.117.078220
Research ArticleArticle
Metabolism and Disposition of Verinurad, a Uric Acid Reabsorption Inhibitor, in Humans
Caroline A. Lee, Chun Yang, Vishal Shah, Zancong Shen, David M Wilson, Traci M. Ostertag, Jesse Hall, Jean-Luc Girardet and Michael Gillen
Drug Metabolism and Disposition February 28, 2018, dmd.117.078220; DOI: https://doi.org/10.1124/dmd.117.078220
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement